Late dosing of common luteinizing hormone-releasing hormone (LHRH) agonists used for androgen deprivation therapy (ADT) in prostate cancer occurs frequently, a researcher reported. Late dosing was ...
Home security giant ADT disclosed in late April 2026 that hackers broke into cloud-based systems storing customer data. The ...